GlyCardial Diagnostics
Spin-off company of the Catalan Institute of Cardiovascular Sciences (ICCC) and the Spanish National Research Council (CSIC) focused on the development of a novel in vitro diagnostic device for myocardial ischemia.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD14—22m (Dealroom.co estimates Nov 2017.)
Company register number B67079186
Barcelona Catalonia (HQ)
- hard tech
- biotechnology
- horizon europe
- woman founder
- sustainable development goals
- spinout
- eit ecosystem
- cardiology
- eit health
- eit supernovas
- health it
- health diagnostics
- headstart (eit health)
- european health catapult (eit health)
- microbiology
- biomarkers
- headstart 2018 (eit health)
- european health catapult 2018 (eit health)
- caixa impulse (eit health)
- digital sandbox (eit health)
- digital sandbox 2020 (eit health)
- caixa impulse 2015 (eit health)
Authorizing premium user...